
The primary aim of this phase I trial was to assess the tolerance of cancer patients to focused ultrasound zzso treatment in a variety of different sites and to document any associated acute or delayed zzso This would appear to be the first time that treatment has been given without sedation or zzso 

Patients with advanced and/or zzso disease were eligible for entry into this zzso Previous work has established that an in zzso zzso intensity zzso of 1500 zzso zzso for 1 s achieves zzso necrosis at the focal zzso zzso zzso of zzso of zzso for 1 s were delivered to zzso tissue zzso zzso questionnaires recording any side effects were completed by the patient and the investigator zzso zzso images of the target volume were taken before, immediately after, and 1 week after zzso 

A total of 14 patients have been entered into this study to zzso Seven patients were treated at their primary site and seven received treatment to one of their zzso No treatment needed to be stopped because of zzso Eight of the 14 patients did not complain of any side effect during or after the zzso One patient complained of mild, and two of moderate pain during the week following zzso One patient developed an zzso zzso on the zzso 

zzso ultrasound is a safe, zzso and zzso method of delivering zzso zzso energy to selected zzso More clinical trials are needed to assess the role of this zzso in the treatment of zzso 

